BackRydex Biotechnology Inv Overview

Rydex Biotechnology Inv Total Liabilities

Rydex Biotechnology Inv's total liabilities is $1B.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$1.04B
↓ 0.41% YoYΔ $-4.32M vs prior year quarter

Peer trimmed avg / median

Loading

Rydex Biotechnology Inv Total Liabilities History

Loading

Rydex Biotechnology Inv vs. peers: Total Liabilities Comparison

Loading

Rydex Biotechnology Inv Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Rydex Biotechnology Inv (RYOIX) FAQ

Rydex Biotechnology Inv (RYOIX) currently reports a total liabilities of $1B as of December 2023. That compares with $1B in the prior-year period — down 0.4% year over year. Use the charts on this page to explore Rydex Biotechnology Inv's total liabilities history and peer comparisons.

Rydex Biotechnology Inv's total liabilities decreased from $1B to $1B — a 0.4% year-over-year decrease (period ending December 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Rydex Biotechnology Inv reported $1B in total liabilities as of December 2023. That compares with $1B in the prior-year period — down 0.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $1B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Rydex Biotechnology Inv, and consider following RYOIX for alerts when major investors trade the stock.

Questions & Answers